A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
about
Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic AcidExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsProtein transduction therapy into cochleae via the round window niche in guinea pigs.Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability.High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides.Transdermal Delivery of siRNA through Microneedle ArrayExpression, purification and production of antisera against recombinant truncated VP22 proteinHyperosmotic treatment synergistically boost efficiency of cell-permeable peptides.Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery.Emerging antitumor applications of extracellularly reengineered polymeric nanocarriers.Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Strategies to stabilize cell penetrating peptides for in vivo applications.High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA.Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.Controlling toxicity of Peptide-drug conjugates by different chemical linker structures.Cell-penetrating peptides with intracellular organelle targeting.In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy.Dendrimeric Guanidinoneomycin for Cellular Delivery of Bio-macromolecules.Advances in therapeutic bacterial antisense biotechnology.Functionalised nanostructures for transdermal delivery of drug cargos.Enzymatic activation of cell-penetrating peptides in self-assembled nanostructures triggers fibre-to-micelle morphological transition.Coiled-Coil-Mediated Activation of Oligoarginine Cell-Penetrating Peptides.Peptide inhibition of the SETD6 methyltransferase catalytic activity.Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways.Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicinesMembrane Active Peptides and Their Biophysical Characterization
P2860
Q26774462-5F9C57F4-42C9-400C-B3BD-E247BB3CDA4DQ28075692-FF7782B9-9465-4526-9E78-F12338B06010Q30375640-66BC3E52-9763-4449-974A-6A1DC55D8FF6Q35785197-A1FDEBB4-4CA4-44FC-BADF-58CC3C7E0A5DQ35818922-81F4108B-B150-41C8-B526-483F7E241C46Q36090102-A6FE0C4E-AAB1-4A37-91C2-125126D953E3Q36591373-498DD7DE-74C1-4ECE-832B-523988AC46AAQ36824998-788ACFFF-DB70-475E-BF29-9FAE750E57C0Q37688827-8822B666-034B-4CE8-A8B1-2D2AD16A5494Q37735811-FFD32307-604F-4DDC-A297-E2CBEA01BFF1Q38383279-1E87342A-2A6D-47EF-B543-1712864FBD6DQ38556756-F8173596-F6AA-4051-A457-9E8EAFFBE318Q38595154-65758152-F710-456A-A283-C5FC71E305DFQ38602460-41DCF690-56A7-488B-8EB4-1E806280E0CEQ38651811-BFB43808-D05C-4AF4-939C-0544B9C2C542Q38658534-6864D6DB-CDBB-4EE9-AA0E-F4C31DC68A68Q38882129-02A933A7-6B70-4FA8-83FC-001105FAE24DQ38900020-C0676D18-A8D2-4ECC-9B5D-5FEDCC2C4DD7Q39790895-DDA6399D-84C7-4EC9-B12A-FA384D68A757Q46699693-72FE95FE-6922-4342-B533-AF8FF93CF4C7Q47325247-2F10B0AF-EA1E-4A71-97D1-695290A91162Q47738254-F11CC389-FE1B-4D76-AC0E-7421ED844C07Q48019999-0100E396-6C10-4281-AA43-983746AD8B03Q48209703-6837A313-0E41-4A1F-82B1-FF2B2A09F7FBQ50052960-3E5A2A90-9105-4847-B3C7-7BAB13E677F9Q50083508-DD60A05A-82B5-4DCB-94FC-2887183E4540Q57073301-DBE97B54-31FF-428E-A447-A7FEA6AA637BQ58717273-2B96315A-50AA-4DDC-BE37-116EDEA5D064
P2860
A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A survey on "Trojan Horse" pep ...... nd controlled entry to "Troy".
@en
type
label
A survey on "Trojan Horse" pep ...... nd controlled entry to "Troy".
@en
prefLabel
A survey on "Trojan Horse" pep ...... nd controlled entry to "Troy".
@en
P1476
A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy"
@en
P2093
Nian-Qiu Shi
P356
10.1016/J.JCONREL.2014.08.014
P407
P577
2014-08-23T00:00:00Z